SARS-COV-2 Omicron variant predicted to exhibit higher affinity to ACE-2 receptor and lower affinity to a large range of neutralizing antibodies, using a rapid computational platform
Adam T Zemla, Thomas Desautels, Edmond Y. Lau, Fangqiang Zhu, Kathryn T. Arrildt, Brent W. Segelke, Shankar Sundaram, Daniel Faissol
The paper predicts the SARS-CoV-2 Omicron variant has higher ACE-2 binding affinity and reduced neutralizing antibody binding compared to Delta and other variants using computational methods.
bioRxiv · Dec 16, 2021 · PreprintBioinformatics